Synopsys builds the software that powers every chip designed for AI, and analysts are practically falling over each other to ...

For much of the past year, Synopsys (NASDAQ:SNPS) was a stock investors argued about more than celebrated. It had piled on ...

Synopsys (NasdaqGS:SNPS) is adopting NVIDIA CUDA-X libraries and the cuPotential library for AI-driven semiconductor ...

A team of medical device engineers has published a risk-aware methodology for selecting the finite element mesh ...

SiC and GaN thermal management relies on multiscale simulation spanning device-level FEA to system-level electro-thermal ...

Smart contact lenses have long hovered at the edge of science fiction: transparent displays floating in the field of vision, ...

Synopsys CEO Sassine Ghazi talks about AI agents, the limits of autonomous engineering, digital twins, and the challenges ...

Life does not always proceed according to the blueprint you first drew. I myself advanced from a technical high school to ...

The US Digital Twins in Healthcare Market was valued at USD 0.87 Billion in 2025 and is expected to grow at a 41.34% CAGR to reach USD 27.34 Billion by 2035.

BofA raised its Synopsys target from USD 500.00 to USD 600.00 on October 1, 2026. Synopsys guided to USD 11.10 billion in ...

Synopsys could emerge as a major winner from the next phase of AI growth, but its ambitious 2030 targets come with important valuation risks.